Sign in or Register   Sign in or Register
  |  

Mouse Anti-MYBL1 Recombinant Antibody (4-E3) (CBMAB-A4587-YC)

Provided herein is a Mouse monoclonal antibody against Human MYB Proto-Oncogene Like 1. The antibody can be used for immunoassay techniques, such as WB, IP.
See all MYBL1 antibodies

Summary

Host Animal
Mouse
Specificity
Human, Mouse, Frog
Clone
4-E3
Antibody Isotype
IgG2a
Application
WB, IP

Basic Information

Immunogen
Recombinant full length v-myb protein, DNA binding protein
Specificity
Human, Mouse, Frog
Antibody Isotype
IgG2a
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
v-myb myeloblastosis viral oncogene homolog (avian)-like 1
Introduction
MYBL1 (MYB Proto-Oncogene Like 1) is a protein coding gene. Diseases associated with MYBL1 include Burkitt Lymphoma and Breast Adenoid Cystic Carcinoma. Among its related pathways are Mitotic Prophase and Gene Expression. Gene Ontology (GO) annotations re
Entrez Gene ID
Human4603
Mouse17864
Frog100491549
UniProt ID
HumanP10243
MouseP51960
FrogQ05935
Alternative Names
MYB Proto-Oncogene Like 1; V-Myb Avian Myeloblastosis Viral Oncogene Homolog-Like 1; Myb-Like Protein 1; A-MYB; AMYB; Myb-Related Protein A;
Function
Transcription factor that specifically recognizes the sequence 5'-YAAC[GT]G-3' (PubMed:8058310, PubMed:7987850).

Acts as a master regulator of male meiosis by promoting expression of piRNAs: activates expression of both piRNA precursor RNAs and expression of protein-coding genes involved in piRNA metabolism (By similarity).

The piRNA metabolic process mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and governs the methylation and subsequent repression of transposons, which is essential for the germline integrity (By similarity).

Transcriptional activator of SOX30 (By similarity).
Biological Process
Cell differentiation Source: UniProtKB-KW
Male meiosis I Source: UniProtKB
Mitotic cell cycle Source: GO_Central
Negative regulation of transposition Source: UniProtKB
piRNA biosynthetic process Source: UniProtKB
Positive regulation of transcription, DNA-templated Source: UniProtKB
Positive regulation of transcription by RNA polymerase II Source: NTNU_SB
Regulation of transcription, DNA-templated Source: GO_Central
Spermatogenesis Source: UniProtKB
Cellular Location
Nucleus

Säflund, M., & Özata, D. M. (2023). The MYBL1/TCFL5 transcription network: two collaborative factors with central role in male meiosis. Biochemical Society Transactions, 51(6), 2163-2172.

Ueda, K., Murase, T., Kawakita, D., Nagao, T., Kusafuka, K., Nakaguro, M., ... & Inagaki, H. (2023). The landscape of MYB/MYBL1-and peri-MYB/MYBL1-associated rearrangements in adenoid cystic carcinoma. Modern Pathology, 36(10), 100274.

Persson, M., Andersson, M. K., Mitani, Y., Brandwein-Weber, M. S., Frierson Jr, H. F., Moskaluk, C., ... & Stenman, G. (2022). Rearrangements, expression, and clinical significance of myb and Mybl1 in adenoid cystic carcinoma: A multi-institutional study. Cancers, 14(15), 3691.

Zhu, J., Wu, Y., Yu, Y., Li, Y., Shen, J., & Zhang, R. (2022). MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma. Cell Death & Disease, 13(8), 727.

Xu, J., Wang, B., & Zhang, D. (2022). LncRNA ENSMUST00000171502 induced by HIF-1α ameliorates ischemic acute kidney injury via targeting the miR-130b-3p/Mybl-1 axis. Cells, 11(23), 3747.

Nikolaus, M., Koch, A., Stenzel, W., Elezkurtaj, S., Sahm, F., Tietze, A., ... & Knierim, E. (2022). Atypical NMDA receptor expression in a diffuse astrocytoma, MYB-or MYBL1-altered as a trigger for autoimmune encephalitis. Acta Neuropathologica, 144(2), 385-389.

Wefers, A. K., Stichel, D., Schrimpf, D., Coras, R., Pages, M., Tauziède-Espariat, A., ... & Capper, D. (2020). Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course. Acta neuropathologica, 139, 193-209.

Ellison, D. W., Hawkins, C., Jones, D. T., Onar-Thomas, A., Pfister, S. M., Reifenberger, G., & Louis, D. N. (2019). cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF V600E mutation. Acta neuropathologica, 137, 683-687.

Chiang, J., Harreld, J. H., Tinkle, C. L., Moreira, D. C., Li, X., Acharya, S., ... & Ellison, D. W. (2019). A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration. Acta neuropathologica, 138, 1091-1092.

Pei, J., Flieder, D. B., Patchefsky, A., Talarchek, J. N., Cooper, H. S., Testa, J. R., & Wei, S. (2019). Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing. Modern Pathology, 32(10), 1416-1420.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-MYBL1 Recombinant Antibody (4-E3)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare